Transforming nephrology care delivery: a non-incremental approach to eliminate the use of race-based clinical algorithms
Racialized clinical algorithms have existed in medicine and scientific research for decades. However, using race-based algorithms to diagnose and manage disease is fundamentally flawed given that race is a social rather than biological construct. We will explore the controversial use of race in a widely used clinical algorithm (estimated glomerular filtration rate) in nephrology and examine its associated ethical and scientific challenges. Further, we will delve into the strategies used to eliminate this approach and review current national guidelines and federal policies that ensure sustainability of changes.
Amaka Eneanya, MD, MPH
Chief Transformation Officer, Emory HealthcareAmaka Eneanya, MD, MPH, is currently the Chief Transformation Officer at Emory Healthcare. The goal of the Transformation Office is to optimize patient and employee experiences from end to end. Prior to this position, she was Head of Strategy and Operations, Global Medical Office, at Fresenius Medical Care – a global dialysis company. Dr. Eneanya graduated cum laude with a bachelor’s degree in sociology from Cornell University, holds a medical degree with honors from Meharry Medical College, and a master’s degree in public health from the Harvard T.H. Chan School of Public Health. She completed her training at Harvard Medical School’s main teaching hospitals – first, internal medicine residency at Brigham and Women’s Hospital followed by nephrology training at the combined program at Massachusetts General Hospital/Brigham and Women’s Hospital.
Register for March 31, 2025, 3-4pm
